253 related articles for article (PubMed ID: 28532503)
1. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor quantitative measures and breast cancer survival.
Hill DA; Barry M; Wiggins C; Nibbe A; Royce M; Prossnitz E; Lomo L
Breast Cancer Res Treat; 2017 Dec; 166(3):855-864. PubMed ID: 28825224
[TBL] [Abstract][Full Text] [Related]
3. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
[TBL] [Abstract][Full Text] [Related]
4. The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment.
Mittendorf EA; Vila J; Tucker SL; Chavez-MacGregor M; Smith BD; Symmans WF; Sahin AA; Hortobagyi GN; Hunt KK
JAMA Oncol; 2016 Jul; 2(7):929-36. PubMed ID: 26986538
[TBL] [Abstract][Full Text] [Related]
5. Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.
Forsare C; Bak M; Falck AK; Grabau D; Killander F; Malmström P; Rydén L; Stål O; Sundqvist M; Bendahl PO; Fernö M
BMC Cancer; 2018 Dec; 18(1):1226. PubMed ID: 30526533
[TBL] [Abstract][Full Text] [Related]
6. Incorporating progesterone receptor expression into the PREDICT breast prognostic model.
Grootes I; Keeman R; Blows FM; Milne RL; Giles GG; Swerdlow AJ; Fasching PA; Abubakar M; Andrulis IL; Anton-Culver H; Beckmann MW; Blomqvist C; Bojesen SE; Bolla MK; Bonanni B; Briceno I; Burwinkel B; Camp NJ; Castelao JE; Choi JY; Clarke CL; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Ernst K; Evans DG; Figueroa JD; Fink V; Floris G; Fox S; Gabrielson M; Gago-Dominguez M; García-Sáenz JA; González-Neira A; Haeberle L; Haiman CA; Hall P; Hamann U; Harkness EF; Hartman M; Hein A; Hooning MJ; Hou MF; Howell SJ; ; ; Ito H; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kristensen VN; Kwong A; Lambrechts D; Li J; Lubiński J; Manoochehri M; Margolin S; Matsuo K; Taib NAM; Mulligan AM; Nevanlinna H; Newman WG; Offit K; Osorio A; Park SK; Park-Simon TW; Patel AV; Presneau N; Pylkäs K; Rack B; Radice P; Rennert G; Romero A; Saloustros E; Sawyer EJ; Schneeweiss A; Schochter F; Schoemaker MJ; Shen CY; Shibli R; Sinn P; Tapper WJ; Tawfiq E; Teo SH; Teras LR; Torres D; Vachon CM; van Deurzen CHM; Wendt C; Williams JA; Winqvist R; Elwood M; Schmidt MK; García-Closas M; Pharoah PDP
Eur J Cancer; 2022 Sep; 173():178-193. PubMed ID: 35933885
[TBL] [Abstract][Full Text] [Related]
7. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
8. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
[TBL] [Abstract][Full Text] [Related]
9. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
12. Which women decide to take tamoxifen?
Narod SA; Sopik V; Sun P
Breast Cancer Res Treat; 2017 Jul; 164(1):149-155. PubMed ID: 28374324
[TBL] [Abstract][Full Text] [Related]
13. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
14. An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy.
Grootes I; Wishart GC; Pharoah PDP
NPJ Breast Cancer; 2024 Jan; 10(1):6. PubMed ID: 38225255
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer.
Wishart GC; Rakha E; Green A; Ellis I; Ali HR; Provenzano E; Blows FM; Caldas C; Pharoah PD
BMC Cancer; 2014 Dec; 14():908. PubMed ID: 25472026
[TBL] [Abstract][Full Text] [Related]
17. Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.
Jayasekara H; MacInnis RJ; Chamberlain JA; Dite GS; Leoce NM; Dowty JG; Bickerstaffe A; Win AK; Milne RL; Giles GG; Terry MB; Eccles DM; Southey MC; Hopper JL
Int J Cancer; 2019 Dec; 145(12):3207-3217. PubMed ID: 30771221
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an extended Cox prognostic model for patients with ER/PR+ and HER2- breast cancer: a retrospective cohort study.
Xie Y; Li X; Wu Y; Cui W; Liu Y
World J Surg Oncol; 2022 Oct; 20(1):338. PubMed ID: 36224558
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and comparison of different breast cancer prognosis scores based on gene expression data.
Chowdhury A; Pharoah PD; Rueda OM
Breast Cancer Res; 2023 Feb; 25(1):17. PubMed ID: 36755280
[TBL] [Abstract][Full Text] [Related]
20. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With Breast Cancer: Retrospective Study.
Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
